October 22, 2025
FDA Issues Warning Letters to CBD and Mushroom Pet Supplement Manufacturers

The U.S. Food and Drug Administration has issued warning letters to three pet product companies for marketing unapproved animal drug products containing CBD and mushroom-based supplements, according to an announcement from the National Animal Supplement Council (NASC). Companies Cited and Violation Details The warning letters, posted by the FDA on April 7, 2025, targeted: House […]

Read More
crossmenu